Clinical Trials Browser

OTHER × Interventional × Hemangioendothelioma × Clear all

NCT07477548 2026-03-17

A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies

Phase 2 Not yet recruiting

67 enrolled

Arteriovenous Malformations, Hemangioendothelioma, Hemangioma, Lymphangioma, Nevus, Vascular Malformations

NCT04008238 2026-03-06

PIPER

Phase NA Completed

29 enrolled

Sarcoma

Hemangioendothelioma, Sarcoma, Sarcoma, Synovial, Histiocytoma, Malignant Fibrous, Solitary Fibrous Tumors

NCT03277924 2024-08-13

Chondrosarcoma, Extraskeletal Myxoid, Bone Neoplasms, Chondrosarcoma, Hemangioendothelioma, Hemangiosarcoma, Leiomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Hemangioendothelioma, Epithelioid, Histiocytoma, Malignant Fibrous, Solitary Fibrous Tumors

NCT05324384 2024-01-24

Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma

Phase 2 Unknown

30 enrolled

Kaposiform Hemangioendothelioma, Hemangioendothelioma

NCT02110069 2023-09-21

A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors

Phase 2 Terminated

4 enrolled 8 charts

Tufted angioma, Kaposiform Hemangioendothelioma, Hemangioendothelioma, Vascular Malformations, Kasabach-Merritt Syndrome

Clinical Trials

A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies

PIPER

ImmunoSarc

Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma

A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors